CBP501: Completed Phase II enrollment

CanBas completed enrollment of 192 patients in an open-label, international Phase II trial comparing 25 mg/m 2 IV CBP501 in combination with 500 mg/m 2 IV pemetrexed and 75 mg/m 2 IV cisplatin given o...